Trademark Attorney / Law Firm
James Hamraie – Trademark Portfolio
James Hamraie has filed 5 trademarks with the United States Patent and Trademark Office (USPTO). Filing records span from 2022 to 2024, covering 2 years of intellectual property practice. Of these filings, 1 is currently registered. The portfolio covers 5 Nice Classification classes, with the highest concentration in Class 35 (Advertising & Business, 2 filings) and Class 16 (Paper Goods, 1 filings).
Showing of trademarks Trademarks
Practice Areas by Trademark Class
James Hamraie's trademark practice covers 5 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.
Advertising; business management; business administration; office functions
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademark applications has James Hamraie filed?
James Hamraie has filed 5 trademark applications with the United States Patent and Trademark Office (USPTO). Of these, 1 registered, 4 abandoned.
What trademark classes does James Hamraie specialize in?
James Hamraie has filed trademarks across 5 Nice Classification classes. The most common practice areas include Class 35 (Advertising & Business), Class 16 (Paper Goods), Class 5 (Pharmaceuticals), Class 34 (Smokers Articles), Class 39 (Transportation & Storage). Class 35 covers advertising; business management; business administration; office functions.
How long has James Hamraie been filing trademarks?
James Hamraie's trademark filing history with the USPTO spans from 2022 to 2024, covering 2 years of trademark practice. During this period, James Hamraie has handled 5 trademark applications.
What is James Hamraie's trademark registration success rate?
James Hamraie has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.